1,100
Participants
Start Date
November 18, 2019
Primary Completion Date
February 1, 2030
Study Completion Date
February 1, 2030
Ublituximab
Ublituximab (TG-1101) is a recombinant chimeric monoclonal antibody targeting CD20, available as a 25 mg/mL concentrate for intravenous use, supplied by TG Therapeutics, Inc.
TG Investigational Trial Site, Zagreb
TG Therapeutics Investigational Trial Site, Zhytomyr
TG Therapeutics Investigational Trial Site, Belgrade
TG Therapeutics Investigational Trial Site, Chernihiv
TG Therapeutics Investigational Trial Site, Chernihiv
TG Therapeutics Investigational Trial Site, Amherst
TG Therapeutics Investigational Trial Site, Cherkasy
TG Therapeutics Investigational Trial Site, Vinnytsia
TG Therapeutics Investigational Trial Site, Osijek
TG Therapeutics Investigational Trial Site, Miami
TG Therapeutics Investigational Trial Site, Tampa
TG Therapeutics Investigational Trial Site, Kragujevac
TG Therapeutics Investigational Trial Site, Poltava
TG Therapeutics Investigational Trial Site, Knoxville
TG Therapeutics Investigational Trial Site, Varaždin
TG Therapeutics Investigational Trial Site, Westerville
TG Therapeutics Investigational Trial Site, Columbus
TG Therapeutics Investigational Trial Site, Ternopil
TG Therapeutics Investigational Trial Site, Detroit
TG Therapeutics Investigational Trial Site, Chernivtsi
TG Therapeutics Investigational Trial Site, Northbrook
TG Therapeutics Investigational Trial Site, Kharkiv
TG Therapeutics Investigational Trial Site, Kharkiv
TG Therapeutics Investigational Trial Site, Kharkiv
TG Therapeutics Investigational Trial Site, Odesa
TG Therapeutics Investigational Trial Site, Kansas City
TG Therapeutics Investigational Trial Site, Zaporizhia
TG Therapeutics Investigational Trial Site, Frisco
TG Therapeutics Investigational Trial Site, Dallas
TG Therapeutics Investigational Trial Site, Ivano-Frankivsk
TG Therapeutics Investigational Trial Site, San Antonio
TG Therapeutics Investigational Trial Site, Round Rock
TG Therapeutics Investigational Trial Site, Lviv
TG Therapeutics Investigational Trial Site, Lviv
TG Therapeutics Investigational Trial Site, Denver
TG Therapeutics Investigational Trial Site, Albuquerque
TG Therapeutics Investigational Trial Site, Uzhhorod
TG Therapeutics Investigational Trial Site, Las Vegas
TG Therapeutics Investigational Trial Site, Pasadena
TG Therapeutics Investigational Trial Site, Zaporizhia
TG Therapeutics Investigational Trial Site, Seattle
TG Therapeutics Investigational Trial Site, Moscow
TG Therapeutics Investigational Trial Site, Moscow
TG Therapeutics Investigational Trial Site, Arkhangelsk
TG Therapeutics Investigational Trial Site, Saint Petersburg
TG Therapeutics Investigational Trial Site, Saint Petersburg
TG Therapeutics Investigational Trial Site, Saint Petersburg
TG Therapeutics Investigational Trial Site, Smolensk
TG Therapeutics Investigational Trial Site, Minsk
TG Therapeutics Investigational Trial Site, Minsk
TG Therapeutics Investigational Trial Site, Minsk
TG Therapeutics Investigational Trial Site, Grodno
TG Therapeutics Investigational Trial Site, Bryansk
TG Therapeutics Investigational Trial Site, Kursk
TG Therapeutics Investigational Trial Site, Grodno
TG Therapeutics Investigational Trial Site, Pyatigorsk
TG Therapeutics Investigational Trial Site, Saransk
TG Therapeutics Investigational Trial Site, Ufa
TG Therapeutics Investigational Trial Site, Chelyabinsk
TG Therapeutics Investigational Trial Site, Nizhny Novgorod
TG Therapeutics Investigational Trial Site, Yekaterinburg
TG Therapeutics Investigational Trial Site, Tyumen
TG Therapeutics Investigational Trial Site, Novosibirsk
TG Therapeutics Investigational Trial Site, Novosibirsk
TG Therapeutics Investigational Trial Site, Tomsk
TG Therapeutics Investigational Trial Site, Kemerovo
TG Therapeutics Investigational Trial Site, Barnaul
TG Therapeutics Investigational Trial Site, Krasnoyarsk
TG Therapeutics Investigational Trial Site, Teaneck
TG Therapeutics Investigational Trial Site, Tbilisi
TG Therapeutics Investigational Trial Site, Tbilisi
TG Therapeutics Investigational Trial Site, Tbilisi
TG Therapeutics Investigational Trial Site, Tbilisi
TG Therapeutics Investigational Trial Site, Tbilisi
TG Therapeutics Investigational Trial Site, Tbilisi
TG Therapeutics Investigational Trial Site, Katowice
TG Therapeutics Investigational Trial Site, Katowice
TG Therapeutics Investigational Trial Site, Katowice
TG Therapeutics Investigational Trial Site, Krakow
TG Therapeutics Investigational Trial Site, Lodz
TG Therapeutics Investigational Trial Site, Olsztyn
TG Therapeutics Investigational Trial Site, Poznan
TG Therapeutics Investigational Trial Site, Warsaw
TG Therapeutics Investigational Trial Site, Zabrze
TG Therapeutics Investigational Trial Site, Kyiv
TG Therapeutics Investigational Trial Site, Kyiv
TG Therapeutics, Inc.
INDUSTRY